Winship Cancer Institute is categorized under Noncommercial Research Organizations in Atlanta, GA and active since 2010.
Winship Cancer Institute was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Earistean Ward at the company’s single location by writing to 2564 Hatfield Circle Se, Atlanta, Georgia GA 30316 or by phoning (404) 941-3680. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Winship Cancer Institute |
| Contact Person: | Earistean Ward |
| Address: | 2564 Hatfield Circle Se, Atlanta, Georgia 30316 |
| Phone Number: | (404) 941-3680 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Winship Cancer Institute was started in 2010 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Earistean Ward for inquiries that concern Winship Cancer Institute by calling the company number (404) 941-3680, as your correspondence is most welcome. Additionally, the physical location of the single location of Winship Cancer Institute can be found at the coordinates 33.713653,-84.338578 as well as the street address 2564 Hatfield Circle Se in Atlanta, Georgia 30316.
For its online presence, you may visit Winship Cancer Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.